Literature DB >> 6973429

Cultured T lymphocytes cytotoxic for a syngeneic lymphoma: derivation in Con A-conditioned medium and in vivo activity.

J Bertoglio, D Gerlier, J P Gerard.   

Abstract

Cultures of murine T lymphocytes with cytotoxic activity towards syngeneic RBL-5 lymphoma cells were obtained from spleen cells of immunized animals after co-culture in vivo with irradiated RBL-5 cells. At different times after initiation, these mixed tumour-lymphocyte cultures (MTLC) were multiplied by transfer to conditioned medium (CM) containing T cell growth factor (TCGF) activity, produced by the stimulation of rat spleen cells with Con A. The effect of residual Con A was investigated by the addition of specific blocking sugar, alpha-methyl mannoside (alpha MM), to the CM in some experiments. This procedure did not reduce the growth potential of the cells, and resulted in a dramatic increase in the cytotoxic activity of the cultures as measured by a 4-hr 51Cr-release assay. The cultures multiplied 1 X 10(3)-fold over a 3-week period with retention of cytotoxicity for RBL-5 cells at levels up to 70-fold greater than those of the MTLCs from which they were derived. The cultured cells, when injected i.p. together with RBL-5 cells into normal mice, were shown to mediate a significant prolongation of the survival of the treated animals. This effect was, however, less dramatic than had been expected from the in vitro results. It would therefore appear that, while cells grown in tissue culture using Con A-conditioned medium may fulfill some theoretical requirements for the immunotherapy of experimental tumours, other factor(s) are required for full protection.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6973429      PMCID: PMC1537218     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Studies on T lymphocyte activation II. The target cells for concanavalin A-induced growth factors.

Authors:  A Coutinho; E L Larsson; K O Grönvik; J Andersson
Journal:  Eur J Immunol       Date:  1979-08       Impact factor: 5.532

2.  Studies on T lymphocyte activation. I. Requirements for the mitogen-dependent production of T cell growth factors.

Authors:  J Andersson; K O Grönvik; E L Larsson; A Coutinho
Journal:  Eur J Immunol       Date:  1979-08       Impact factor: 5.532

3.  Specificity of in vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells.

Authors:  M Röllinghoff; N L Warner
Journal:  Proc Soc Exp Biol Med       Date:  1973-12

4.  Reconstitution of the antibody response in vitro of T cell-deprived spleen cells by supernatants from spleen cell cultures.

Authors:  O Sjöberg; J Andersson; G Möller
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

5.  Ligand-activated T cell growth factor-induced proliferation: absorption of T cell growth factor by activated T cells.

Authors:  G D Bonnard; K Yasaka; D Jacobson
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

6.  Comparative studies on the induction of transplantation resistance in BALB-c and C57BL-6 mice in three murine leukemia systems.

Authors:  J L McCoy; A Fefer; J P Glynn
Journal:  Cancer Res       Date:  1967-10       Impact factor: 12.701

7.  Selective reconstitution of nude mice with long-term cultured and cloned specific helper T cells.

Authors:  R Tees; M H Schreier
Journal:  Nature       Date:  1980-02-21       Impact factor: 49.962

8.  Prevention of transplantable tumors by adoptive transfer of spleen cells from immunized rats.

Authors:  D C Fish; D B Djurickovic; R J Huebner
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

9.  Continuous proliferation of murine antigen-specific helper T lymphocytes in culture.

Authors:  J Watson
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

10.  Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines.

Authors:  J Watson; S Gillis; J Marbrook; D Mochizuki; K A Smith
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

View more
  2 in total

1.  Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.

Authors:  T Yamasaki; H Handa; J Yamashita; Y Watanabe; Y Namba; M Hanaoka
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

2.  Specificity studies on cytolytic T lymphocytes directed against murine leukemia virus-induced tumors. Analysis of monoclonal cytolytic T lymphocytes.

Authors:  F Plata
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.